Literature DB >> 28947296

Home-based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic-based treatment in patients with stable disease: A retrospective study of 40 patients.

Solam Lee1, Won-Soo Lee2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28947296     DOI： 10.1016/j.jaad.2017.09.037

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Economic Impact of Home-Use versus Office-Use Diphenylcyclopropenone in Extensive Alopecia Areata.

Authors:  Chinmanat Lekhavat; Pinyo Rattanaumpawan; Isree Juengsamranphong
Journal:  Skin Appendage Disord       Date:  2021-11-22

2.  Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.

Authors:  Solam Lee; Beom Jun Kim; Young Bin Lee; Won-Soo Lee
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

3.  Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO).

Authors:  David G Li; Kathie P Huang; Fan Di Xia; Cara Joyce; Deborah A Scott; Abrar A Qureshi; Arash Mostaghimi
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

Review 4.  Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update.

Authors:  Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Tanaporn Anuntrangsee; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

Review 5.  Alopecia Areata: An Autoimmune Disease of Multiple Players.

Authors:  Poonkiat Suchonwanit; Chaninan Kositkuljorn; Cherrin Pomsoong
Journal:  Immunotargets Ther       Date:  2021-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.